Genetic Engineering & Biotechnology News : Tech advances will help cell therapy makers cope with variable starting materials
“Autologous cell therapies are made from living cells, harvested from specific people. Every batch of inputs is...
Biotechgate – BioCardia and CellProthera Enhance Collaboration
” BioCardia and CellProthera Enhance Collaboration for Development of ProtheraCytes™ for the Treatment of Acute Myocardial Infarction...
The Medicine Maker – Stem Cells: The Next (Re)generation
“Through its Phase I/IIb EXCELLENT clinical trial, CellProthera, a France-based biotechnology research company focusing on cardiac tissue...
DDW – Where is the global innovation and the opportunity in cell and gene therapy?
Investment landscape In 2023, Matthieu de Kalbermatten, CEO of CellProthera, looks forward to presenting the final safety...
DDW – Can Europe become a major player in cell and gene therapy?
Posted in DDW Exclusive Content, Market Reports | Tagged Advanced Therapy Medicinal Products (ATMPs), Alliance for Regenerative...
DAILY MAIL – Stem cells breakthrough that could help thousands of heart patients
Pat Wilkinson, from Gloucester, suffered ill health after developing heart failure. She was given a pacemaker, but...
DAILY EXPRESS – Stem cells treatment can save lives and NHS cash
MILLIONS of heart failure patients could be saved thanks to a new stem cell therapy being tested...